10 medicines held by Lipomed GmbH on the Irish market, from the HPRA register of authorised products.
| Medicine | Active substance | Licence holder | Status |
|---|---|---|---|
| Dacarbazine Lipomed 1000 mg powder for solution for infusion PA1760/001/003 |
Dacarbazine | Lipomed GmbH | Marketed |
| Dacarbazine Lipomed 200 mg powder for solution for injection or infusion PA1760/001/001 |
Dacarbazine | Lipomed GmbH | Marketed |
| Dacarbazine Lipomed 500 mg powder for solution for infusion PA1760/001/002 |
Dacarbazine | Lipomed GmbH | Marketed |
| Deferiprone Lipomed 500 mg Film-coated tablet EU/1/18/1310/001 |
Deferiprone | Lipomed GmbH | — |
| Jayempi 10 mg/ml oral suspension EU/1/21/1557/001 |
Azathioprine | Lipomed GmbH | — |
| Litak 2 mg/ml solution for injection EU/1/04/275/001-002 |
Cladribine | Lipomed GmbH | — |
| Qaialdo 10 mg/ml oral suspension EU/1/23/1731/001 |
Spironolactone | Lipomed GmbH | — |
| Thalidomide Lipomed 100 mg coated tablets EU/1/22/1676/001 |
Thalidomide | Lipomed GmbH | — |
| Xaluprine 20 mg/ml oral suspension EU/1/11/727/001 |
Mercaptopurine monohydrate | Lipomed GmbH | — |
| Xromi 100 mg/ml oral solution EU/1/19/1366/001 |
Hydroxycarbamide | Lipomed GmbH | — |
Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 20 August 2026).
Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.